MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis
about
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory controlMetalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics.Extracellular matrix modulates angiogenesis in physiological and pathological conditions.Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression.Identification of α2-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritisRheumatoid arthritis and salivary biomarkers of periodontal disease.Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.Salivary biomarkers for detection of systemic diseasesCytosolic phospholipase A2 regulates TNF-induced production of joint destructive effectors in synoviocytes.The transcription factor MEF2C negatively controls angiogenic sprouting of endothelial cells depending on oxygenMMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.Matrix metalloproteinase-2 and -9 activities in the human lens epithelial cells and serum of steroid induced posterior subcapsular cataracts.Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases.Chondrogenic differentiation of human subchondral progenitor cells is affected by synovial fluid from donors with osteoarthritis or rheumatoid arthritisDecreasing cartilage damage in a rat model of osteoarthritis by intra-articular injection of deoxycholic acidIntraarticular Matrix Metalloproteinases and Aggrecan Degradation Are Elevated After Articular Fracture.Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of OsteoarthritisProteinases in the joint: clinical relevance of proteinases in joint destructionRational design of antirheumatic prodrugs specific for sites of inflammation.Resistance of MMP9 and TIMP1 to endotoxin tolerance.Pathogenesis of endometriosis: the role of defective 'immunosurveillance'.Persisting high levels of synovial fluid markers after cartilage repair: a pilot studyDeoxycytidine kinase promotes the migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge.A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft.Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis.Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model.Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients.A multiparameter approach to monitor disease activity in collagen-induced arthritis.Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes.Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells.15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.Association of aggressive periodontitis with reduced erythrocyte counts and reduced hemoglobin levels.Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs.Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis.Low-Molecular-Weight Fucoidan Inhibits the Viability and Invasiveness and Triggers Apoptosis in IL-1β-Treated Human Rheumatoid Arthritis Fibroblast Synoviocytes.Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes.Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery.Structural insights into the binding mode of flavonols with the active site of matrix metalloproteinase-9 through molecular docking and molecular dynamic simulations studies.
P2860
Q24817102-8ADCDACB-1E09-4E3C-ACD1-A2E5BF63CF99Q33660754-C82AD122-384F-47D8-9842-7AA1259C0028Q33737210-5B774662-74A2-4077-B2A8-C3A68523E976Q34152675-9323675B-83E4-4CE9-A09F-F4576CA8C633Q34296547-91685AAA-2524-42BB-8B90-7AF5DCF876ADQ34306262-0864CF11-190F-4596-97C4-FF22F7228C2BQ34545102-6F284E5D-CCDB-4086-87A0-A3C59A72886EQ34700220-C250941B-7158-45F9-931F-3CC93CC4665DQ35071024-31616AB3-EEF5-4E71-9A50-3DFA363C7536Q35200237-A38063EC-92C7-47F2-9FFF-681DF63B1CA7Q35555490-8B4833B0-B8BE-4E12-9FF9-82F43B9C6906Q35605620-7505784D-35A6-4D4D-9AA9-7229ADFF693AQ35677331-150E1A58-71AD-4D76-9B01-E146E36F4FF4Q35911136-6242AFA2-D6CF-4220-B457-D3A7FB528A03Q35950874-09C4CA0F-2C82-4908-8D26-547DF74A5A2FQ35959470-B8B4503C-C59F-4E00-8FF7-659D1873C34EQ36037778-64F722B7-E196-49C9-80A1-9456D30E5CA2Q36204519-88956846-3DA1-457D-8E49-D1D4EB6B25FAQ36401848-75E5CA1E-911B-49DE-8900-D112CFEBB230Q36799824-3376251D-430D-4A17-AE69-61E38D34A8FEQ36848047-9BD6B7DC-AD2D-4BAA-A473-0A659A524948Q36925666-B4E5E548-27B0-4D67-849D-9833209691FEQ37011640-6FC65506-A738-4A49-9916-234146FA5A18Q37349455-8840AA0B-B355-4E4E-8FA0-D82C9B0C517EQ37379755-A25654F4-CF03-45AB-969E-D0FDDE422385Q38966155-5CD2B3C1-FDB2-47D8-AF42-6F0842AE9B72Q39970029-BCE35128-E80B-42DF-B7FD-0DBA6BC47E00Q40213039-5AD6A34E-1A23-4A28-BE71-35F10B616390Q41934025-8A447631-D870-4433-AD56-863D6B00E8DDQ42420307-8CFE1999-FA7C-40A5-8BC0-D5502E6524C6Q42558370-B04349C4-7619-4CEE-A851-74141A78B822Q43084969-C2A767EF-A5EA-4271-A1F9-0047028D6AF8Q43514279-3C1D4591-1A82-45DC-99A8-4013B4FB930CQ45892368-65781579-013C-4652-B2F5-BABD50E6EE7DQ46390941-9EA1364A-D6C1-46B4-89CD-3534F2FD8A0FQ46406275-8EBB9E59-FF75-4F89-956D-A33106C48C72Q46757023-C5F38C70-6F09-492A-9DB1-017824AEF97AQ47293883-51BE825E-E740-428C-84A2-AAB4A882FF3DQ47333777-ED1E7FFA-7BBD-41B5-B0D1-1A963CAEBC71Q47412161-4FDBDA32-F98A-4F9F-A481-875CFE15785B
P2860
MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
MMP profile in paired serum an ...... ents with rheumatoid arthritis
@ast
MMP profile in paired serum an ...... ents with rheumatoid arthritis
@en
type
label
MMP profile in paired serum an ...... ents with rheumatoid arthritis
@ast
MMP profile in paired serum an ...... ents with rheumatoid arthritis
@en
prefLabel
MMP profile in paired serum an ...... ents with rheumatoid arthritis
@ast
MMP profile in paired serum an ...... ents with rheumatoid arthritis
@en
P2093
P356
P1476
MMP profile in paired serum an ...... ents with rheumatoid arthritis
@en
P2093
H K Ronday
I Tchetverikov
J M TeKoppele
R Hanemaaijer
T W J Huizinga
P304
P356
10.1136/ARD.2003.013243
P407
P577
2004-07-01T00:00:00Z